Local Institution
Lucca 55100
0 studies enrolling now · 5 studies all time
What they study most
Lung Cancer - Non Small Cell Squamous, Non Small Cell Lung Cancer, Small Cell Lung Carcinoma, Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Non-small Cell Lung Cancer
Studies at this site
- Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens — Completed
- Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer — Completed
- Phase I Combination Ixabepilone + Cisplatin — Completed
- Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone — Completed
- Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin — Completed